Products

• FDA approved topical treatment in Androgenetic Alopecia²
• Its special formulation allows lighter and less greasy texture
• Effective in improving hair density^3,4
• Suitable for adults, men or women
• Made in France

Minoxidil 2%

For the treatment of moderate hair loss, called androgenetic alopecia, in adults, men or women. It promotes hair growth and stabilizes the hair loss phenomenon.

Apply a 1 mL dose (6 sprays) on the scalp twice a day, beginning from the centre of the area to be treated.

60 mL bottle with a dispensing pump. Box of 1 or 3 bottles.

For details, please refer to the package insert.

Keep out of the reach and sight of children.

The content on this site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or pharmacist with any questions you may have regarding a medical condition.

Reference

1. Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-553. doi:10.1016/j.jaad.2003.06.014
2. Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759-3781. doi:10.1111/jocd.14537
3. Olsen EA, Weiner MS, Amara IA, DeLong ER. Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol. 1990;22(4):643-646. doi:10.1016/0190-9622(90)70089-z
4. Olsen EA, Whiting D, Bergfeld W, et al. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2007;57(5):767-774. doi:10.1016/j.jaad.2007.04.012